This is only for the XL 300 extended use and the 150 strength is not affected so one less extended Wellbutrin generic out there. There are other generics of Wellbutrin. The FDA stated this particular generic version failed to release the the same amount of the drug into the blood stream at the same rate as the name brand. The FDA also said they are going to test 4 other generic manufacturers and compare it as well so we shall see what the next test results bring. There’s no danger here just the fact that the anti depressant might not be doing as good as a job as it should. BD
WASHINGTON—The highest strength of a generic version of the antidepressant Wellbutrin, marketed by a unit of Teva Pharmaceuticals Ltd., TEVA -1.04% will be taken off the U.S. market after tests showed it didn't work as well as the brand-name drug.
The U.S. Food and Drug Administration said Wednesday the product, Budeprion XL 300 milligrams, which is manufactured by Impax Laboratories Inc. IPXL -2.33% and marketed by Teva Pharmaceuticals USA Inc., "is not therapeutically equivalent to Wellbutrin XL 300 mg" or the extended-release version of Wellbutrin.
Impax has requested that the FDA withdraw approval of the product, the agency said. Impax and Teva have stopped shipping the product.